tert-Butyl (3R,4R)-4-amino-3-methylpiperidine-1-carboxylate

Catalog No. :
ACYEKP943
CAS No. :
723308-58-5
Molecular Formula :
C11H22N2O2
Molecular Weight :
214.31

IUPAC Name:tert-butyl (3R,4R)-4-amino-3-methylpiperidine-1-carboxylate

tert-Butyl (3R,4R)-4-amino-3-methylpiperidine-1-carboxylate structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
100mg98%$154.00Login to see priceIn stockIn stock
250mg98%$245.00Login to see priceIn stockIn stock
1g98%$613.00Login to see priceIn stockIn stock
5g98%$2122.00Login to see priceIn stockInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Nametert-Butyl (3R,4R)-4-amino-3-methylpiperidine-1-carboxylate
IUPAC Nametert-butyl (3R,4R)-4-amino-3-methylpiperidine-1-carboxylate
MDL No.MFCD22396720
Molecular FormulaC11H22N2O2
Molecular Weight214.31
SMILESO=C(N1C[C@@H](C)[C@H](N)CC1)OC(C)(C)C
InChI KeyUMBWKSXEVUZEMI-RKDXNWHRSA-N
Synonym1428341-13-2 | 723308-58-5 | tert-butyl trans-4-amino-3-methylpiperidine-1-carboxylate | TERT-BUTYL (3R,4R)-4-AMINO-3-METHYLPIPERIDINE-1-CARBOXYLATE | (3R,4R)-4-amino-3-methyl-piperidine-1-carboxylic acid tert-butyl ester | trans-1-Boc-3-methylpiperidin-4
CAS No.723308-58-5
PubChem CID66998328

Safety Data

Pictogram
CorrosiveHarmful or irritant
Signal Word
Gefahr
Hazard Statement(s)
H302-H315-H318-H335
Precautionary Statement(s)
P280-P301+P312+P330-P302+P352-P305+P351+P338+P310

Synthetic Route by SureRoute

1. ACYEKP943 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACYEKP943 route product structure diagram
    ACYEKP943723308-58-5 In Stock
Inquiry

2. ACYEKP943 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACYEKP943 route product structure diagram
    ACYEKP943723308-58-5 In Stock
Inquiry

Comments (0)